\nLa c\u00e2teva zile dup\u0103 ce Lars Fruergaard J\u00f8rgensen a preluat rolul de CEO al companiei Novo Nordisk \u00een 2017 a luat deja decizia ce va culmina \u00een explozia pe burs\u0103 a companiei, scrie Financial Times.<\/p>\n
\nGigantul farmaceuit nu lansase \u00eenc\u0103 Ozempic, medicamentul pentru diabet popularizat de vedete datorit\u0103 propriet\u0103\u0163ilor de sl\u0103bire, \u015fi era la ani distan\u0163\u0103 de aprobarea Wegovy, versiunea care \u0163inte\u015fte obezitatea. La acea vreme echipa de management dezb\u0103tea dac\u0103 s\u0103 \u00eenceap\u0103 costisitorul proces de testare care ar fi urmat s\u0103 dovedeasc\u0103, sau nu, c\u0103 Wegovy reduce riscul de AVC \u015fi infarct.<\/p>\n
\nPariul \u00eenceput de Lars Fruergaard J\u00f8rgensen a dat rezultate: Datele ini\u0163iale au ar\u0103tat c\u0103 pacien\u0163ii care au folosit Wegovy au avut un risc mai mic cu 20% pentru a dezvolta boli cardiovasculare.<\/p>\n
\nInvestitorii au \u00eenceput s\u0103 spere ca adop\u0163ia medicamentului va salva vie\u0163i \u015fi va reduce costurile pentru sistemele de s\u0103n\u0103tate. Compania a crescut cu 16% pe burs\u0103 \u00een acea zi \u015fi a continuat avansul p\u00e2n\u0103 a ajuns cea mai valoroas\u0103 companie din Europa.<\/p>\n
\nJ\u00f8rgensen s-a al\u0103turat companiei Novo Nordisk \u00een 1991 dup\u0103 ce a studiat Finance and Business \u015fi a lucrat \u00een mai multe sedii ale companiei \u00een SUA, Japonia \u015fi Olanda. Acesta \u015fi-a \u00eent\u00e2lnit so\u0163ia la locul de munc\u0103, av\u00e2nd \u00eempreun\u0103 cu ea doi copii.<\/p>\n
\nCEO-ul Novo Nordisk consider\u0103 responsibilitatea o tr\u0103s\u0103tur\u0103 cheie \u00een via\u0163\u0103, dar subliniaz\u0103 importan\u0163a reflec\u0163iei, merg\u00e2nd adesea cu caiacul pe lacul din apropierea casei sale.<\/p>\n
\nLars Green, CFO-ul companiei sor\u0103 Novozymes, \u00eel cunoa\u015fte pe J\u00f8rgensen \u00eenc\u0103 din facultate. \u201eA \u00eenv\u0103\u0163at c\u0103 lucrurile nu vin de la sine. Ele necesit\u0103 investi\u0163ie sau efort \u015fi, pe baza acestora, \u00ee\u0163i prime\u015fti recompensa.\u201d<\/p>\n
\nEmily Field, analist la Barclays, a explicat c\u0103 J\u00f8rgensen nu s-a pus \u00een prim planul conferin\u0163ei companiei la anun\u0163area veniturilor precum al\u0163i lideri din industrie. \u201eNu s-a f\u0103cut pe sine fa\u0163a companiei, oamenii apreciaz\u0103 foarte mult asta. Este vorba despre Novo Nordisk, nu despre el.\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"
La c\u00e2teva zile dup\u0103 ce Lars Fruergaard J\u00f8rgensen a preluat rolul de CEO al companiei Novo Nordisk \u00een 2017 a luat deja decizia ce va culmina \u00een explozia pe burs\u0103 a companiei, scrie Financial Times. Gigantul farmaceuit nu lansase \u00eenc\u0103 Ozempic, medicamentul pentru diabet popularizat de vedete datorit\u0103 propriet\u0103\u0163ilor de sl\u0103bire, \u015fi era la ani […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[510],"tags":[40199,7216,55611,55609,25380,55610,55608,55607,15494,16559,322,34037,26600,55612],"class_list":["post-219428","post","type-post","status-publish","format-standard","hentry","category-actualitate","tag-avc","tag-bursa","tag-diabetic","tag-fruergaard","tag-infarct","tag-jorgensen","tag-lars","tag-lars-fruergaard-jorgensen","tag-novo-nordisk","tag-obezitate","tag-ozempic","tag-slabire","tag-slabit","tag-wegovy"],"_links":{"self":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/219428","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=219428"}],"version-history":[{"count":0,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/219428\/revisions"}],"wp:attachment":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=219428"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=219428"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=219428"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}